164 related articles for article (PubMed ID: 14691303)
21. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.
Han Y; Amin HM; Franko B; Frantz C; Shi X; Lai R
Blood; 2006 Oct; 108(8):2796-803. PubMed ID: 16825495
[TBL] [Abstract][Full Text] [Related]
22. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
23. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.
Taylor KH; Pena-Hernandez KE; Davis JW; Arthur GL; Duff DJ; Shi H; Rahmatpanah FB; Sjahputera O; Caldwell CW
Cancer Res; 2007 Mar; 67(6):2617-25. PubMed ID: 17363581
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
Hayslip J; Montero A
Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
[TBL] [Abstract][Full Text] [Related]
26. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
Li Y; Liu X; Guo X; Liu X; Luo J
Leuk Res; 2017 Jul; 58():9-13. PubMed ID: 28376405
[TBL] [Abstract][Full Text] [Related]
27. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms.
Yano T; Sander CA; Andrade RE; Gauwerky CE; Croce CM; Longo DL; Jaffe ES; Raffeld M
Blood; 1993 Sep; 82(6):1813-9. PubMed ID: 8400234
[TBL] [Abstract][Full Text] [Related]
29. Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms.
Grønbaek K; Ralfkiaer U; Dahl C; Hother C; Burns JS; Kassem M; Worm J; Ralfkiaer EM; Knudsen LM; Hokland P; Guldberg P
Mod Pathol; 2008 May; 21(5):632-8. PubMed ID: 18264085
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the monocyte-specific esterase (MSE) gene.
Uphoff CC; Hu ZB; Gignac SM; Ma W; Rainey FA; Kreutz M; Ludwig WD; Drexler HG
Leukemia; 1994 Sep; 8(9):1510-26. PubMed ID: 8090031
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
33. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
34. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.
Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL
Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
36. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
[TBL] [Abstract][Full Text] [Related]
37. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
38. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
[TBL] [Abstract][Full Text] [Related]
39. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma.
Kondo T; Oka T; Sato H; Shinnou Y; Washio K; Takano M; Morito T; Takata K; Ohara N; Ouchida M; Shimizu K; Yoshino T
Int J Oncol; 2009 Sep; 35(3):547-57. PubMed ID: 19639175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
